17
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Efecto antinflamatorio de la asociación dexametasona con ketorolaco o diclofenaco en cirugía de tercer molar. Ensayo clínico aleatorizado Translated title: Anti-inflammatory effect of the dexamethasone association with ketorolac or diclofenac in third molar surgery. Randomized clinical trial

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          RESUMEN Objetivo: Evaluar el efecto antinflamatorio de la asociación dexametasona con diclofenaco y la asociación dexametasona con ketorolaco en cirugía de tercer molar mandibular. Material y método: Ensayo clínico aleatorizado doble ciego que incluyó 75 pacientes que se dividieron aleatoriamente en tres grupos: el grupo DK recibió la asociación dexametasona con ketorolaco; el grupo DD, la asociación dexametasona con diclofenaco y el grupo control D, solo dexametasona; todos por vía intramuscular, treinta minutos antes de la cirugía. El efecto antinflamatorio se determinó por la evaluación del dolor y la tumefacción postquirúrgicos. El dolor se evaluó mediante la escala visual análoga y el consumo total de analgésicos. La tumefacción se evalúo mediante las medidas de tumefacción facial y la apertura bucal. Resultados: El grupo DD evidenció menor intensidad de dolor a las 4, 6, 12, 24 y 48 horas en comparación a los otros grupos de tratamiento (p < 0,05). El consumo total de analgésicos fue significativamente menor en el grupo DD (1,20 ± 0,3) en comparación con los otros grupos de tratamiento (p = 0,002). La tumefacción facial fue similar en todos los grupos de estudio (p > 0,05). El grupo DD evidenció una significativa mayor apertura bucal solamente a las 48 horas postoperatorias en comparación a los otros grupos de estudio (p = 0,01). Conclusiones: La administración preoperatoria de la asociación dexametasona con diclofenaco presenta una significativa mayor actividad analgésica en comparación a la administración preoperatoria de la asociación dexametasona con ketorolaco. Sin embargo, no hay diferencia significativa con relación a la tumefacción facial.

          Translated abstract

          ABSTRACT Objective: To evaluate the antiinflammatory effect of the association dexamethasone with diclofenac and the association dexamethasone with ketorolac in mandibular third molar surgery. Material and method: Randomized double blind clinical trial that included 75 patients who were randomly divided into three groups: the DK group received the dexamethasone association with ketorolac; the DD group, the dexamethasone association with diclofenac and the control group D, only dexamethasone; all intramuscularly, thirty minutes before surgery. The anti-inflammatory effect was determined by the evaluation of postoperative pain and swelling. The pain was evaluated by means of the analogous visual scale and the total analgesic consumption. Swelling was assessed by measures of facial swelling and mouth opening. Results: The DD group showed less pain intensity at 4 h, 6 h, 12 h, 24 h and 48 h compared to the other treatment groups (p < 0.05). Total analgesic consumption was significantly lower in the DD group (1.20 ± 0.3) compared to the other treatment groups; p = 0.002. Facial swelling was similar in all study groups (p > 0.05). The DD group showed a significant greater oral opening only at 48 hours postoperatively compared to the other study groups (p = 0.01). Conclusions: The preoperative administration of the dexamethasone association with diclofenac has a significantly greater analgesic activity compared to the preoperative administration of the dexamethasone association with ketorolac. However, there is no significant difference in relation to facial swelling.

          Related collections

          Most cited references23

          • Record: found
          • Abstract: found
          • Article: not found

          Letters, numbers, symbols and words: how to communicate grades of evidence and recommendations.

          The GRADE Working Group is developing and evaluating a common, sensible approach to grading quality of evidence and strength of recommendations in health care. In this article, we discuss the advantages and disadvantages of using letters, numbers, symbols or words to represent grades of evidence and recommendations. Using multiple strategies, we searched for comparative studies of alternative ways of representing ordered categories in any context. In addition, we contacted experts and reviewed theoretical work and qualitative research on how best to communicate grades of any kind quickly and clearly. We were unable to identify health care research that addressed, either directly or indirectly, the best way to present grades of evidence and recommendations. We found examples of symbols used by government, commercial and consumer organizations to communicate quality of evidence or strength of recommendations, but no comparative studies. Although a number of grading systems are used in health care and other fields, there is little or no evidence of how well various presentations are understood. Before promoting the use of specific symbols, numbers, letters or words, the extent to which the intended message is comprehended should be evaluated.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Update on the endorsement of CONSORT by high impact factor journals: a survey of journal “Instructions to Authors” in 2014

            Background The CONsolidated Standards Of Reporting Trials (CONSORT) Statement provides a minimum standard set of items to be reported in published clinical trials; it has received widespread recognition within the biomedical publishing community. This research aims to provide an update on the endorsement of CONSORT by high impact medical journals. Methods We performed a cross-sectional examination of the online “Instructions to Authors” of 168 high impact factor (2012) biomedical journals between July and December 2014. We assessed whether the text of the “Instructions to Authors” mentioned the CONSORT Statement and any CONSORT extensions, and we quantified the extent and nature of the journals’ endorsements of these. These data were described by frequencies. We also determined whether journals mentioned trial registration and the International Committee of Medical Journal Editors (ICMJE; other than in regards to trial registration) and whether either of these was associated with CONSORT endorsement (relative risk and 95 % confidence interval). We compared our findings to the two previous iterations of this survey (in 2003 and 2007). We also identified the publishers of the included journals. Results Sixty-three percent (106/168) of the included journals mentioned CONSORT in their “Instructions to Authors.” Forty-four endorsers (42 %) explicitly stated that authors “must” use CONSORT to prepare their trial manuscript, 38 % required an accompanying completed CONSORT checklist as a condition of submission, and 39 % explicitly requested the inclusion of a flow diagram with the submission. CONSORT extensions were endorsed by very few journals. One hundred and thirty journals (77 %) mentioned ICMJE, and 106 (63 %) mentioned trial registration. Conclusions The endorsement of CONSORT by high impact journals has increased over time; however, specific instructions on how CONSORT should be used by authors are inconsistent across journals and publishers. Publishers and journals should encourage authors to use CONSORT and set clear expectations for authors about compliance with CONSORT.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Assessment of factors associated with surgical difficulty in impacted mandibular third molar extraction.

              The aim of this prospective study was to investigate radiologic and clinical factors associated with increased difficulty in the removal of impacted mandibular third molars. We also aimed to form an index to measure the difficulty of removal of the impacted molars preoperatively. A total of 87 patients who required 90 surgical extractions of impacted mandibular third molars from November 2003 to May 2004 were involved in the study. Radiologic and clinical data were taken preoperatively. All extractions were performed under local anesthesia by a single operator. Surgical difficulty was measured by the total intervention time. Increased surgical difficulty was associated with increasing age and body mass index. It was also associated with the curvature of roots of the impacted tooth and the depth from point of elevation (P < .05). Both clinical and radiologic variables are important in predicting surgical difficulty in impacted mandibular third molar extractions.
                Bookmark

                Author and article information

                Journal
                maxi
                Revista Española de Cirugía Oral y Maxilofacial
                Rev Esp Cirug Oral y Maxilofac
                Sociedad Española de Cirugía Oral y Maxilofacial y de Cabeza y Cuello (Madrid, Madrid, Spain )
                1130-0558
                2173-9161
                September 2020
                : 42
                : 3
                : 119-126
                Affiliations
                [2] Lima Lima orgnameUniversidad Nacional Mayor de San Marcos orgdiv1Facultad de Odontología Peru
                [3] Lima Lima orgnameUniversidad Nacional Mayor de San Marcos orgdiv1Facultad de Odontología orgdiv2Laboratorio de Farmacología Peru
                [1] Lima Lima orgnameUniversidad Científica del Sur orgdiv1Facultad de Ciencias de la Salud orgdiv2Laboratorio de Farmacología Peru
                Article
                S1130-05582020000300004 S1130-0558(20)04200300004
                10.20986/recom.2020.1053/2019
                73709fcb-f185-405e-b3e5-7cb022dbf4a4

                This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

                History
                : 15 February 2019
                : 05 February 2019
                Page count
                Figures: 0, Tables: 0, Equations: 0, References: 25, Pages: 8
                Product

                SciELO Spain

                Categories
                Originales

                analgesia preventiva,cirugía de tercer molar,Dexamethasone,ketorolaco,diclofenac,diclofenaco,ketorolac,Dexametasona,preventive analgesia,third molar surgery

                Comments

                Comment on this article